Calopad

Lucerne, Switzerland

Calopad, the world's thinnest MDR/FDA-certified wearable for targeted, side-effect-free heat and cold therapy for pain relief and recovery.

$4.5M raised

Aug 2023

Seed

Top Investors

Technology Fund

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Calopad raised?

Calopad has raised $4.5M in total funding. The most recent round was Seed. The last funding was announced in August 2023.

Who are Calopad's investors?

Calopad's investors include Technology Fund.

Where is Calopad headquartered?

Calopad is headquartered in Lucerne, Switzerland.

What does Calopad do?

Calopad, the world's thinnest MDR/FDA-certified wearable for targeted, side-effect-free heat and cold therapy for pain relief and recovery.

What stage is Calopad at?

Calopad is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 25, 2023.

MLA

"Calopad — Funding & Investors." VCBacked, August 25, 2023, https://www.vcbacked.co/company/calopad. Accessed June 4, 2026.

APA

VCBacked. (2023). Calopad — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/calopad

Wikipedia (cite web)

{{cite web |title=Calopad — Funding & Investors |url=https://www.vcbacked.co/company/calopad |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 25, 2023.